Markets

Medical Transcription prices IPO at $5 as expected

Medical Transcription Billing, which provides a SaaS platform for ambulatory care facilities, raised $20 million by offering 4.1 million shares at $5, its revised IPO price. The company initially filed to offer 3.0 million shares at a range of $9 to $11, but slashed its price to $5 and increased shares offered in an amendment filed last week. Medical Transcription Billing will list on the NASDAQ under the symbol MTBC. Chardan Capital Markets, Aegis Capital and Summer Street Research Partners acted as joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MTBC

Other Topics

IPOs